Making Sense of Today’s 340B Policy Entanglements | The Future of Pharmacy Podcast
Listen now
Description
Making Sense of Today’s 340B Policy Entanglements
As covered entities face rising healthcare costs, reimbursement cuts, and uncompensated care, the Federal 340B Drug Pricing Program continues to be an important source of funding for vital patient care. Get updates on how the 340B program solutions can help providers manage reporting compliance across an increasingly complex pharmacy supply chain, while capturing drug cost savings.
Guest Expert: Ted Slafsky, Publisher and CEO, 340B Report
Host: Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More Episodes
The high cost and complexity of specialty medications often contribute to adherence issues that negatively impact patient outcomes. Increasing adherence requires streamlined access to specialty medications and clear and frequent communication with patients to discuss dosage, frequency, side...
Published 01/31/23
Published 01/31/23
Recent technological advanceshave provided a solution to historical challenges with IV automation. These enhancements allow technicians to increase production and ensure greater accuracy while reducing human error or variationrisks. In either case, making it easier than before. Huntsville...
Published 11/22/22
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
